Scope Fluidics First Quarter 2025 Earnings: zł4.03 loss per share (vs zł2.51 loss in 1Q 2024)

Scope Fluidics (WSE:SCP) First Quarter 2025 Results

Key Financial Results

• Net loss: zł11.0m (loss widened by 61% from 1Q 2024).
• zł4.03 loss per share (further deteriorated from zł2.51 loss in 1Q 2024).

We've discovered 2 warning signs about Scope Fluidics. View them for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Scope Fluidics Earnings Insights

Looking ahead, revenue is expected to decline by 55% p.a. on average during the next 3 years, while revenues in the Medical Equipment industry in Europe are expected to grow by 6.9%.

Performance of the market in Poland.

The company's shares are down 8.6% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Scope Fluidics has 2 warning signs (and 1 which doesn't sit too well with us) we think you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.